P
papaspicy
Guest
I recently heard that one of the reasons why the scientific community really wants to expand embryonic stem cell research is that any cures and advances made from this method can be patented, and hence be profitable for the researcher. On the other hand, progress from adult stem cell research can’t be turned into money in the hands of the researcher (according to the current patent laws). Is this true? Is there somewhere I can learn more about this? What would be the reason for the disparity in this issue?